Every year we eagerly await the American Society of Hematology (ASH) late breaking abstract reveal. They can be sublime or disappointing, depending on the data available.
This year the conference is back in sunny San Diego.
We’ve already created some order from the chaos of the initial data dump and highlighted some key abstracts to watch out for in our first Preview post in the ASH18 series.
This time we look at what’s in store and – more importantly – what can we learn about the chosen LBA selections? What sort of caveats do we need to be mindful of?
It turns out that that’s quite a bit to think about…